Mansour Al‐Moundhri

ORCID: 0000-0003-3963-1232
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Colorectal Cancer Screening and Detection
  • Ovarian cancer diagnosis and treatment
  • Helicobacter pylori-related gastroenterology studies
  • Global Cancer Incidence and Screening
  • Cancer-related Molecular Pathways
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Cancer-related molecular mechanisms research
  • Chemotherapy-induced organ toxicity mitigation
  • Palliative Care and End-of-Life Issues
  • Colorectal Cancer Treatments and Studies
  • Cancer Treatment and Pharmacology
  • Economic and Financial Impacts of Cancer
  • Cancer, Lipids, and Metabolism
  • Patient-Provider Communication in Healthcare
  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Cancer Diagnosis and Treatment
  • RNA modifications and cancer
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • BRCA gene mutations in cancer
  • Lung Cancer Diagnosis and Treatment
  • Cytokine Signaling Pathways and Interactions

Sultan Qaboos University
2013-2022

Sultan Qaboos University Hospital
2006-2022

Creative Commons
2022

Pinderfields Hospital
2020

Yeovil District Hospital NHS Foundation Trust
2020

Royal Hospital
2006-2009

College of Medical Sciences
2006-2009

United Arab Emirates University
2008

Institute of Cancer Research
2001

King's College School
1998

The aim of this study was to explore different psychosocial impacts on Omani women diagnosed with breast cancer.Semi-structured individual interviews were conducted 19 cancer describe the impact disease their personal and social life. Women recruited from wards out-patient clinics at Sultan Qaboos University Hospital, Muscat.Four main themes emerged. These were: a) factors related psychological distress uncertainty (worry death, interference work family responsibilities, searching for...

10.5001/omj.2014.115 article EN cc-by-nc Oman Medical Journal 2014-11-15

PURPOSE Previous studies have reported that cancer incidence trends in Oman varied by tumor site and sex. No comprehensive analysis of all sites had been reported. The objective this study is to analyze calculate the annual percent change (APC) age-standardized rates (ASRs) for all-cancer 61 individual Omani men women from 1996 2019. METHODS We gathered data National Cancer Registry cancers combined sites. estimated APC using Poisson regression. RESULTS ASR population increased 23% (from...

10.1200/go.23.00337 article EN cc-by-nc-nd JCO Global Oncology 2024-01-25

Introduction MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in cancer progression. Neo-adjuvant chemotherapy (NAC) has become the standard of care for locally advanced breast cancer. The aim this study was to evaluate miRNA alterations during NAC using multiple samples tissue and serum correlate expression with clinico-pathological features patient outcomes. Methods Tissue were collected from patients undergoing at four time points: diagnosis, after first fourth cycle...

10.1371/journal.pone.0152032 article EN cc-by PLoS ONE 2016-04-11

Background: Colorectal cancer is the most common gastrointestinal in Oman with an increasing incidence. We here report presenting features, treatment outcomes and survival a University hospital compare our data regional international studies. Materials Methods: Medical records of patients colorectal were reviewed retrospectively between June 2000 December 2013 followed until 2014. Results: A total 162 diagnosed cancer. The majority males (58.6%), median age 56 years. Rectum was involved...

10.7314/apjcp.2015.16.12.4853 article EN cc-by Asian Pacific Journal of Cancer Prevention 2015-07-13

The aim of the present study was to evaluate outcome treatment breast cancer in Oman with an analysis clinico-pathological features, modalities utilized, and prognostic factors. One hundred fifty-two patients diagnosed between January 1996 June 2002 were evaluated retrospectively. Their mean age 48.5 (S.D. +/- 10.8) years, 48% female premenopausal. tumor size according pathology 4.6 3.29)cm, 34.9% 15.8% had stage III or IV disease, respectively. Only 26.3% breast-conserving surgery,...

10.1016/j.breast.2003.10.001 article EN cc-by-nc-nd The Breast 2003-11-15

Breast cancer is the leading cause of cancer-associated mortality in women, with elevated incidence developing countries. This retrospective study included all 122 patients diagnosed breast from January 2003 to December 2008 Sultanate Oman. Age at presentation was 47.41 years (SD±12.88), one-third younger than 40 years. The majority presented stage III (41.2%) and IV (18.2%) cancer. T size (P = .023), skin involvement .003), .004) were significantly associated overall survival. Skin .09),...

10.1155/2011/316243 article EN cc-by Journal of Oncology 2010-10-25

The aim of this study was to identify coping strategies experienced by Omani women after breast cancer diagnosis. Individual semistructured interviews were conducted with 19 diagnosed cancer. Several identified including denial, optimism, withdrawal, Islamic beliefs and practices, the support family members health-care providers, but practices commonest. Health-care professionals should be aware respect women's encourage them use reduce psychological symptoms. They also make friends their...

10.1177/1359105313479813 article EN Journal of Health Psychology 2013-03-21

Abstract Circulating plasma and peripheral blood mononuclear (PBMCs) cells provide an informative snapshot of the systemic physiological state. Moreover, they a non-invasively accessible compartment to identify biomarkers for personalized medicine in advanced breast cancer. The role Neuropilin-1 (NRP-1) its interacting molecules tumor tissue was correlated with cancer progression; however, clinical impact their levels not extensively evaluated. In this cross-sectional study, we found that...

10.1038/s41598-017-03280-0 article EN cc-by Scientific Reports 2017-06-06

Abstract Background The variability of prognosis within a pathological stage gastric cancer (GC) at presentation, underscores the need for specific biological markers to identify subgroups patients with aggressive course intensive treatment. To our knowledge, this is first study from an Arab population reporting on relationship p53, p27 kip1 , p21 waf1 HER‐2/ neu and Ki67 expression, clinicopathological features their prognostic significance. Methods Formalin‐fixed paraffin‐embedded tumors...

10.1002/jso.20324 article EN Journal of Surgical Oncology 2005-08-24

Generation of reactive oxygen species (ROS) is involved in the nephrotoxicity platinum anticancer drugs. This study incubation human embryonic kidney (HEK) 293 cells cell culture media supplemented with cisplatin or oxaliplatin presence absence curcumin, a well-studied antioxidant. Thereafter several indices oxidative stress have been measured, which included glutathione (GSH), total antioxidant capacity (TAC), and enzymes [(superoxide dismutase (SOD), catalase (CAT), peroxidases (GPX)]. The...

10.3109/0886022x.2011.577546 article EN Renal Failure 2011-05-17

Abstract Pathogenesis of nephrotoxicity the synthetic anticancer drug cisplatin (CP) involves generation reactive oxygen species and free radicals in kidney cortex, cysteine prodrug l ‐2‐oxothiazolidine‐4‐carboxylic acid (OTC) has been confirmed to have a strong antioxidant action. Therefore, present work, we aimed at testing possible protective or palliative effect OTC on CP rats. was given an oral dose 150 mg/kg/day for 7 days. On day 7, some these rats were single intraperitoneal...

10.1111/j.1472-8206.2007.00495.x article EN Fundamental and Clinical Pharmacology 2007-09-14

Nephrotoxicity of the anticancer drug, cisplatin (CP) involves enhanced renal generation reactive oxygen metabolites and lipid peroxidation caused by decreased levels antioxidants antioxidant enzymes. Tetramethylpyrazine (TMP) is known to act as a strong antioxidant. Therefore, in present work, we aimed at testing possible protective or palliative effect TMP on CP nephrotoxicity rats. was given orally dose 80 mg . kg(- 1) day(- for 7 days. Some these rats were single intraperitoneal...

10.3181/0711-rm-315 article EN Experimental Biology and Medicine 2008-04-30

Sildenafil, the first drug for erectile dysfunction, has cardiopulmonary protective actions. A recent study reported that sildenafil given intraperitoneally (i.p.) attenuated cisplatin (CP)-induced nephrotoxicity. Here, we evaluated whether sildenafil, by two different routes and at doses, can attenuate CP-induced nephrotoxicity would also affect renal haemodynamics in CP-treated rats. Six groups of rats were treated with saline (controls), CP [5 mg/kg, once], (0.4 mg/kg/day, i.p. 5 days),...

10.1111/j.1742-7843.2011.00724.x article EN Basic & Clinical Pharmacology & Toxicology 2011-05-16

Background: Colorectal cancer (CRC) represents a heterogeneous group of diseases characterized by uncontrolled growth and spread abnormal cells in the body. CRC vary on basis both biologic features disease its associated lifestyle characteristics. The risk increases with several modifiable factors including obesity, physical inactivity, diet high red or processed meat, heavy alcohol consumption, possibly inadequate intake fruits vegetables. We aimed to establish baseline data for dietary...

10.31557/apjcp.2018.19.11.3117 article EN cc-by Asian Pacific Journal of Cancer Prevention 2018-11-01

Background/Objectives: Pharmacogenomic screening plays a crucial role in optimizing chemotherapy outcomes and minimizing toxicity. Characterizing the baseline distribution of genetic variants specific populations is essential to inform prioritization drug–gene combinations for clinical implementation. The objective this study was investigate pharmacogenetic 36 genes related fluoropyrimidine (FP) pathway among healthy Omani individuals, forming foundation future studies cancer patients...

10.3390/genes16050592 article EN Genes 2025-05-17

To analyze the serum levels and prognostic significance of vascular endothelial growth factor (VEGF) -A, -C, -D, their receptors, VEGFR-1 -2 in gastric adenocarcinomas.The VEGF family members were measured 76 control subjects patients with adenocarcinoma using an enzyme-linked immunosorbent assay (ELISA). These measurements correlated clinco-pathological features survival rates.The VEGF-A its receptor, VEGFR-1, significantly higher cancer than healthy donors (t = 2.3, P 0.02 t 4.2, < 0.0001,...

10.3748/wjg.14.3879 article EN cc-by-nc World Journal of Gastroenterology 2008-01-01

Abstract Vascular endothelial growth factor (VEGF) plays a central role in angiogenesis, tumor growth, and metastasis. We investigated the associations between VEGF gene polymorphisms gastric cancer (GC) risk predisposition prognostic characteristics an Omani population, ethnic group which has not been studied previously. analyzed three (+405 G/C, −460 T/C, +936 C/T) by extraction of genomic DNA from peripheral blood 130 GC patients control subjects followed genotyping using polymerase chain...

10.1002/mc.20572 article EN Molecular Carcinogenesis 2009-08-12

AIM:To investigate the associations between CDH1 gene polymorphisms and gastric cancer (GC) risk predisposition. METHODS:We analyzed four (+54 T>C , -160 C>A -616 G>C -3159 ) in an Omani population, by extraction of genomic DNA from peripheral blood 192 patients with GC 170 control participants performed genotyping using sequencing.RESULTS: -AA genotype was associated increased (OR = 3.6, 95% CI: 1.1-11.8)(P 0.03).There no significant association other risk.The haplotype analysis +54...

10.3748/wjg.v16.i27.3432 article EN cc-by-nc World Journal of Gastroenterology 2010-01-01

Abstract Background The adhesion molecule, FAT4, has a tumor suppressor function with critical role in the epithelial-to-mesenchymal-transition (EMT) and anti-malignant growth several cancers. No study investigated yet its epithelial ovarian cancer (EOC) progression. In present study, we examined of FAT4 proliferation metastasis, mechanisms interaction these processes. Methods We have performed cell viability, colony formation, invasion assays cells treated siRNA to knockdown gene...

10.1186/s12885-020-06900-7 article EN cc-by BMC Cancer 2020-05-04
Coming Soon ...